img

Global Tick-borne Encephalitis Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tick-borne Encephalitis Vaccine Market Insights, Forecast to 2034

The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Tick-borne Encephalitis Vaccine estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Tick-borne Encephalitis Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The China market for Tick-borne Encephalitis Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The Europe market for Tick-borne Encephalitis Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The global key manufacturers of Tick-borne Encephalitis Vaccine include Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus and Superdrug Health, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Tick-borne Encephalitis Vaccine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Tick-borne Encephalitis Vaccine market. Further, it explains the major drivers and regional dynamics of the global Tick-borne Encephalitis Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report
Pfizer
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health
Market Segments
This report has explored the key segmentsby Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Tick-borne Encephalitis Vaccine Segment by Type
European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus
Tick-borne Encephalitis Vaccine

Segment by Application


Pediatric Vaccines
Adult Vaccines
Traveler Vaccines
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tick-borne Encephalitis Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes


This report presents an overview of global market for Tick-borne Encephalitis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Tick-borne Encephalitis Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Tick-borne Encephalitis Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tick-borne Encephalitis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Tick-borne Encephalitis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Tick-borne Encephalitis Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus and Superdrug Health, etc.

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Tick-borne Encephalitis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Tick-borne Encephalitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tick-borne Encephalitis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Tick-borne Encephalitis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Tick-borne Encephalitis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 European TBE Virus
1.2.3 Far Eastern TBE Virus
1.2.4 Siberian TBE Virus
1.3 Market by Application
1.3.1 Global Tick-borne Encephalitis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pediatric Vaccines
1.3.3 Adult Vaccines
1.3.4 Traveler Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tick-borne Encephalitis Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Tick-borne Encephalitis Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Tick-borne Encephalitis Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tick-borne Encephalitis Vaccine Sales by Region
2.4.1 Global Tick-borne Encephalitis Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Tick-borne Encephalitis Vaccine by Region (2024-2028)
2.5 Global Tick-borne Encephalitis Vaccine Revenue by Region
2.5.1 Global Tick-borne Encephalitis Vaccine Revenue by Region (2017-2022)
2.5.2 Global Tick-borne Encephalitis Vaccine Revenue by Region (2024-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tick-borne Encephalitis Vaccine Sales by Manufacturers
3.1.1 Global Top Tick-borne Encephalitis Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Tick-borne Encephalitis Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tick-borne Encephalitis Vaccine in 2021
3.2 Global Tick-borne Encephalitis Vaccine Revenue by Manufacturers
3.2.1 Global Tick-borne Encephalitis Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tick-borne Encephalitis Vaccine Revenue in 2021
3.3 Global Tick-borne Encephalitis Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tick-borne Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tick-borne Encephalitis Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tick-borne Encephalitis Vaccine Sales by Type
4.1.1 Global Tick-borne Encephalitis Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Tick-borne Encephalitis Vaccine Forecasted Sales by Type (2024-2028)
4.1.3 Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Tick-borne Encephalitis Vaccine Revenue by Type
4.2.1 Global Tick-borne Encephalitis Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Tick-borne Encephalitis Vaccine Forecasted Revenue by Type (2024-2028)
4.2.3 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Tick-borne Encephalitis Vaccine Price by Type
4.3.1 Global Tick-borne Encephalitis Vaccine Price by Type (2017-2022)
4.3.2 Global Tick-borne Encephalitis Vaccine Price Forecast by Type (2024-2028)
5 Market Size by Application
5.1 Global Tick-borne Encephalitis Vaccine Sales by Application
5.1.1 Global Tick-borne Encephalitis Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Tick-borne Encephalitis Vaccine Forecasted Sales by Application (2024-2028)
5.1.3 Global Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Tick-borne Encephalitis Vaccine Revenue by Application
5.2.1 Global Tick-borne Encephalitis Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Tick-borne Encephalitis Vaccine Forecasted Revenue by Application (2024-2028)
5.2.3 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Tick-borne Encephalitis Vaccine Price by Application
5.3.1 Global Tick-borne Encephalitis Vaccine Price by Application (2017-2022)
5.3.2 Global Tick-borne Encephalitis Vaccine Price Forecast by Application (2024-2028)
6 North America
6.1 North America Tick-borne Encephalitis Vaccine Market Size by Type
6.1.1 North America Tick-borne Encephalitis Vaccine Sales by Type (2017-2028)
6.1.2 North America Tick-borne Encephalitis Vaccine Revenue by Type (2017-2028)
6.2 North America Tick-borne Encephalitis Vaccine Market Size by Application
6.2.1 North America Tick-borne Encephalitis Vaccine Sales by Application (2017-2028)
6.2.2 North America Tick-borne Encephalitis Vaccine Revenue by Application (2017-2028)
6.3 North America Tick-borne Encephalitis Vaccine Market Size by Country
6.3.1 North America Tick-borne Encephalitis Vaccine Sales by Country (2017-2028)
6.3.2 North America Tick-borne Encephalitis Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tick-borne Encephalitis Vaccine Market Size by Type
7.1.1 Europe Tick-borne Encephalitis Vaccine Sales by Type (2017-2028)
7.1.2 Europe Tick-borne Encephalitis Vaccine Revenue by Type (2017-2028)
7.2 Europe Tick-borne Encephalitis Vaccine Market Size by Application
7.2.1 Europe Tick-borne Encephalitis Vaccine Sales by Application (2017-2028)
7.2.2 Europe Tick-borne Encephalitis Vaccine Revenue by Application (2017-2028)
7.3 Europe Tick-borne Encephalitis Vaccine Market Size by Country
7.3.1 Europe Tick-borne Encephalitis Vaccine Sales by Country (2017-2028)
7.3.2 Europe Tick-borne Encephalitis Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tick-borne Encephalitis Vaccine Market Size by Type
8.1.1 Asia Pacific Tick-borne Encephalitis Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Tick-borne Encephalitis Vaccine Market Size by Application
8.2.1 Asia Pacific Tick-borne Encephalitis Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Tick-borne Encephalitis Vaccine Market Size by Region
8.3.1 Asia Pacific Tick-borne Encephalitis Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tick-borne Encephalitis Vaccine Market Size by Type
9.1.1 Latin America Tick-borne Encephalitis Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Tick-borne Encephalitis Vaccine Revenue by Type (2017-2028)
9.2 Latin America Tick-borne Encephalitis Vaccine Market Size by Application
9.2.1 Latin America Tick-borne Encephalitis Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Tick-borne Encephalitis Vaccine Revenue by Application (2017-2028)
9.3 Latin America Tick-borne Encephalitis Vaccine Market Size by Country
9.3.1 Latin America Tick-borne Encephalitis Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Tick-borne Encephalitis Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Type
10.1.1 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Application
10.2.1 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country
10.3.1 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Tick-borne Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Encephalitis
11.2.1 Encephalitis Corporation Information
11.2.2 Encephalitis Overview
11.2.3 Encephalitis Tick-borne Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Encephalitis Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Encephalitis Recent Developments
11.3 Cochrane Collaboration
11.3.1 Cochrane Collaboration Corporation Information
11.3.2 Cochrane Collaboration Overview
11.3.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cochrane Collaboration Recent Developments
11.4 Sonic HealthPlus
11.4.1 Sonic HealthPlus Corporation Information
11.4.2 Sonic HealthPlus Overview
11.4.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sonic HealthPlus Recent Developments
11.5 Superdrug Health
11.5.1 Superdrug Health Corporation Information
11.5.2 Superdrug Health Overview
11.5.3 Superdrug Health Tick-borne Encephalitis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Superdrug Health Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Superdrug Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tick-borne Encephalitis Vaccine Industry Chain Analysis
12.2 Tick-borne Encephalitis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tick-borne Encephalitis Vaccine Production Mode & Process
12.4 Tick-borne Encephalitis Vaccine Sales and Marketing
12.4.1 Tick-borne Encephalitis Vaccine Sales Channels
12.4.2 Tick-borne Encephalitis Vaccine Distributors
12.5 Tick-borne Encephalitis Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tick-borne Encephalitis Vaccine Industry Trends
13.2 Tick-borne Encephalitis Vaccine Market Drivers
13.3 Tick-borne Encephalitis Vaccine Market Challenges
13.4 Tick-borne Encephalitis Vaccine Market Restraints
14 Key Findings in The Global Tick-borne Encephalitis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tick-borne Encephalitis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of European TBE Virus
Table 3. Major Manufacturers of Far Eastern TBE Virus
Table 4. Major Manufacturers of Siberian TBE Virus
Table 5. Global Tick-borne Encephalitis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Tick-borne Encephalitis Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Tick-borne Encephalitis Vaccine Sales by Region (2017-2022) & (K Doses)
Table 8. Global Tick-borne Encephalitis Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Tick-borne Encephalitis Vaccine Sales by Region (2024-2028) & (K Doses)
Table 10. Global Tick-borne Encephalitis Vaccine Sales Market Share by Region (2024-2028)
Table 11. Global Tick-borne Encephalitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2017-2022)
Table 13. Global Tick-borne Encephalitis Vaccine Revenue by Region (2024-2028) & (US$ Million)
Table 14. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2024-2028)
Table 15. Global Tick-borne Encephalitis Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 16. Global Tick-borne Encephalitis Vaccine Sales Share by Manufacturers (2017-2022)
Table 17. Global Tick-borne Encephalitis Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Tick-borne Encephalitis Vaccine Revenue Share by Manufacturers (2017-2022)
Table 19. Tick-borne Encephalitis Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global Tick-borne Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Tick-borne Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tick-borne Encephalitis Vaccine as of 2021)
Table 22. Tick-borne Encephalitis Vaccine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Tick-borne Encephalitis Vaccine Product Offered
Table 24. Date of Manufacturers Enter into Tick-borne Encephalitis Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 27. Global Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 28. Global Tick-borne Encephalitis Vaccine Sales Share by Type (2017-2022)
Table 29. Global Tick-borne Encephalitis Vaccine Sales Share by Type (2024-2028)
Table 30. Global Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 32. Global Tick-borne Encephalitis Vaccine Revenue Share by Type (2017-2022)
Table 33. Global Tick-borne Encephalitis Vaccine Revenue Share by Type (2024-2028)
Table 34. Tick-borne Encephalitis Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 35. Global Tick-borne Encephalitis Vaccine Price Forecast by Type (2024-2028) & (USD/Dose)
Table 36. Global Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 37. Global Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 38. Global Tick-borne Encephalitis Vaccine Sales Share by Application (2017-2022)
Table 39. Global Tick-borne Encephalitis Vaccine Sales Share by Application (2024-2028)
Table 40. Global Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 42. Global Tick-borne Encephalitis Vaccine Revenue Share by Application (2017-2022)
Table 43. Global Tick-borne Encephalitis Vaccine Revenue Share by Application (2024-2028)
Table 44. Tick-borne Encephalitis Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Tick-borne Encephalitis Vaccine Price Forecast by Application (2024-2028) & (USD/Dose)
Table 46. North America Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 47. North America Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 48. North America Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 50. North America Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 51. North America Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 52. North America Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 54. North America Tick-borne Encephalitis Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. North America Tick-borne Encephalitis Vaccine Sales by Country (2024-2028) & (K Doses)
Table 56. North America Tick-borne Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Tick-borne Encephalitis Vaccine Revenue by Country (2024-2028) & (US$ Million)
Table 58. Europe Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 60. Europe Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 62. Europe Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 63. Europe Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 64. Europe Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 66. Europe Tick-borne Encephalitis Vaccine Sales by Country (2017-2022) & (K Doses)
Table 67. Europe Tick-borne Encephalitis Vaccine Sales by Country (2024-2028) & (K Doses)
Table 68. Europe Tick-borne Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Tick-borne Encephalitis Vaccine Revenue by Country (2024-2028) & (US$ Million)
Table 70. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 71. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 72. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 74. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 75. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 76. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 78. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Region (2017-2022) & (K Doses)
Table 79. Asia Pacific Tick-borne Encephalitis Vaccine Sales by Region (2024-2028) & (K Doses)
Table 80. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Tick-borne Encephalitis Vaccine Revenue by Region (2024-2028) & (US$ Million)
Table 82. Latin America Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 83. Latin America Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 84. Latin America Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 86. Latin America Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 87. Latin America Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 88. Latin America Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 90. Latin America Tick-borne Encephalitis Vaccine Sales by Country (2017-2022) & (K Doses)
Table 91. Latin America Tick-borne Encephalitis Vaccine Sales by Country (2024-2028) & (K Doses)
Table 92. Latin America Tick-borne Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Tick-borne Encephalitis Vaccine Revenue by Country (2024-2028) & (US$ Million)
Table 94. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Type (2024-2028) & (K Doses)
Table 96. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Type (2024-2028) & (US$ Million)
Table 98. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Application (2017-2022) & (K Doses)
Table 99. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Application (2024-2028) & (K Doses)
Table 100. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Application (2024-2028) & (US$ Million)
Table 102. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2017-2022) & (K Doses)
Table 103. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2024-2028) & (K Doses)
Table 104. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue by Country (2024-2028) & (US$ Million)
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. Pfizer Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer Recent Developments
Table 111. Encephalitis Corporation Information
Table 112. Encephalitis Description and Major Businesses
Table 113. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. Encephalitis Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Encephalitis Recent Developments
Table 116. Cochrane Collaboration Corporation Information
Table 117. Cochrane Collaboration Description and Major Businesses
Table 118. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cochrane Collaboration Recent Developments
Table 121. Sonic HealthPlus Corporation Information
Table 122. Sonic HealthPlus Description and Major Businesses
Table 123. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sonic HealthPlus Recent Developments
Table 126. Superdrug Health Corporation Information
Table 127. Superdrug Health Description and Major Businesses
Table 128. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Superdrug Health Tick-borne Encephalitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Superdrug Health Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Tick-borne Encephalitis Vaccine Distributors List
Table 134. Tick-borne Encephalitis Vaccine Customers List
Table 135. Tick-borne Encephalitis Vaccine Market Trends
Table 136. Tick-borne Encephalitis Vaccine Market Drivers
Table 137. Tick-borne Encephalitis Vaccine Market Challenges
Table 138. Tick-borne Encephalitis Vaccine Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Tick-borne Encephalitis Vaccine Product Picture
Figure 2. Global Tick-borne Encephalitis Vaccine Market Share by Type in 2021 & 2028
Figure 3. European TBE Virus Product Picture
Figure 4. Far Eastern TBE Virus Product Picture
Figure 5. Siberian TBE Virus Product Picture
Figure 6. Global Tick-borne Encephalitis Vaccine Market Share by Application in 2021 & 2028
Figure 7. Pediatric Vaccines
Figure 8. Adult Vaccines
Figure 9. Traveler Vaccines
Figure 10. Tick-borne Encephalitis Vaccine Report Years Considered
Figure 11. Global Tick-borne Encephalitis Vaccine Sales 2017-2028 (K Doses)
Figure 12. Global Tick-borne Encephalitis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Tick-borne Encephalitis Vaccine Revenue 2017-2028 (US$ Million)
Figure 14. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Tick-borne Encephalitis Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Tick-borne Encephalitis Vaccine Sales Market Share by Region (2024-2028)
Figure 17. North America Tick-borne Encephalitis Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Tick-borne Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Tick-borne Encephalitis Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Tick-borne Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Tick-borne Encephalitis Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Tick-borne Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Tick-borne Encephalitis Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Tick-borne Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Tick-borne Encephalitis Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Tick-borne Encephalitis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Tick-borne Encephalitis Vaccine in the World: Market Share by Tick-borne Encephalitis Vaccine Revenue in 2021
Figure 29. Global Tick-borne Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. North America Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 35. North America Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. North America Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Tick-borne Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 39. North America Tick-borne Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 40. U.S. Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Tick-borne Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 47. Europe Tick-borne Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 48. Germany Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. France Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Tick-borne Encephalitis Vaccine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Tick-borne Encephalitis Vaccine Revenue Share by Region (2017-2028)
Figure 59. China Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. India Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Latin America Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Tick-borne Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 74. Latin America Tick-borne Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 75. Mexico Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Tick-borne Encephalitis Vaccine Revenue Share by Country (2017-2028)
Figure 84. Turkey Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Tick-borne Encephalitis Vaccine Revenue (2017-2028) & (US$ Million)
Figure 87. Tick-borne Encephalitis Vaccine Value Chain
Figure 88. Tick-borne Encephalitis Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed